Agustin Melo Carrillo, MD, PhD

Dr. Agustin Melo Carrillo, MD, PhD is an Assistant Professor of Anesthesia at Harvard Medical School and a principal investigator in the Department of Anesthesia, Critical Care and Pain Medicine at Beth Israel Deaconess Medical Center (BIDMC). His research program is dedicated to understanding the neurobiological mechanisms of migraine, with a particular focus on the trigeminovascular system, cortical spreading depression (CSD), and the actions of CGRP-targeted therapies and botulinum toxin.

Originally from Mexico City, Dr. Melo Carrillo received his medical degree from La Salle University and completed his PhD in Biomedical Sciences at the Universidad Nacional Autónoma de México, during which he also conducted research training at the Centre de Psychiatrie et Neurosciences (Pitié-Salpêtrière. INSERM) in Paris. He joined Harvard Medical School in 2014 as a postdoctoral fellow in the laboratories of Dr. Rami Burstein and Dr. Andrew Strassman, where he developed pioneering approaches to studying headache pain transmission in preclinical models of headache. Dr. Melo Carrillo has led or contributed to over a dozen funded research projects from the NIH and industry, including investigations into narrow band green light therapy, cortical-nociceptive interactions, and the mechanistic roles of CGRP and botulinum toxin in migraine.

Beyond his research activities, Dr. Melo Carrillo is deeply committed to education, mentorship, and expanding access to scientific training. He has mentored a diverse group of undergraduate and graduate trainees, with a particular focus on supporting students from Latin America. He also participates in outreach programs aimed at increasing minority representation in STEM, including hands-on laboratory experiences and career guidance for high school students in the Boston area. Through these efforts, he seeks to foster the next generation of clinician-scientists and create more equitable pathways into academic medicine and neuroscience research.